Tirofiban is superior to aspirin in non-obstructive strokes

Published Date: 08 Mar 2023

Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.

Read Full News

Latest News

Global evidence highlights social roots of HPV vaccine hesitancy

Decisions about the HPV vaccine among adolescents and their families are influenced by a web of social, cultural and trust-related factors, beyond simple awareness or access, a Cochrane review finds.

Cervical cancer vaccine push has saved 1.4 million lives: Gavi

A three-year campaign to bring vaccines against human papillomavirus (HPV) to low-income countries has prevented 1.4 million cervical cancer deaths, the vaccine alliance Gavi said Monday.

Randomized trials show no evidence of non-specific vaccine effects

For more than three decades, researchers Christine Stabell Benn and Peter Aaby from the Bandim Health Project have conducted randomized trials involving thousands of children in Guinea-Bissau and Denmark to demonstrate so-called ...

Philadelphia airport passengers may have been exposed to measles, health officials warn

Passengers traveling through Philadelphia International Airport over the weekend may have been exposed to a case of the measles, city health officials warned Tuesday.

Texas whooping cough cases reach record high, data shows

Pertussis, also known as whooping cough, has reached a record high, with over 3,500 cases reported in Texas to date, according to a Texas Department of State Health Services health alert.

Biovac starts trials on South Africa's first domestically developed cholera vaccine

Researchers and scientists in South Africa on Tuesday launched clinical trials on the first domestically developed vaccine.

Todays Updates

CAR-T Therapy KYV-101 Achieves Durable Response in Phase 2/3 KYSA-6 Trial of Myasthenia Gravis Marco Meglio

KYV-101 shows promising efficacy in treating generalized myasthenia gravis, offering hope for durable remission through innovative CAR T-cell therapy.

Reimagining Neuroscience Trials: Precision, Partnership, and Progress Marco Meglio, Daniel Mikol, MD, PhD

Daniel Mikol, MD, PhD, vice president of neuroscience development at AbbVie, discussed how precision tools, AI, and patient partnership are reshaping the design and execution of modern neuroscience clinical trials.

MIL62 Shows Increased Remission and Reduced Relapse Versus Cyclosporine A in MN

MIL62 Shows Increased Remission and Reduced Relapse Versus Cyclosporine A in MN

AGA Releases Updated Clinical Crohn’s Disease Guideline Reflecting New Therapies

AGA Releases Updated Clinical Crohn’s Disease Guideline Reflecting New Therapies

Skin of Color Savvy: A New Podcast Episode Following SOCS Media Day

Skin of Color Savvy: A New Podcast Episode Following SOCS Media Day

The HCPFive: Top News for Healthcare Providers from the Week of 11/16

The HCPFive: Top News for Healthcare Providers from the Week of 11/16

Todays Updates

CAR-T Therapy KYV-101 Achieves Durable Response in Phase 2/3 KYSA-6 Trial of Myasthenia Gravis Marco Meglio

KYV-101 shows promising efficacy in treating generalized myasthenia gravis, offering hope for durable remission through innovative CAR T-cell therapy.

Reimagining Neuroscience Trials: Precision, Partnership, and Progress Marco Meglio, Daniel Mikol, MD, PhD

Daniel Mikol, MD, PhD, vice president of neuroscience development at AbbVie, discussed how precision tools, AI, and patient partnership are reshaping the design and execution of modern neuroscience clinical trials.

MIL62 Shows Increased Remission and Reduced Relapse Versus Cyclosporine A in MN

MIL62 Shows Increased Remission and Reduced Relapse Versus Cyclosporine A in MN

AGA Releases Updated Clinical Crohn’s Disease Guideline Reflecting New Therapies

AGA Releases Updated Clinical Crohn’s Disease Guideline Reflecting New Therapies

Skin of Color Savvy: A New Podcast Episode Following SOCS Media Day

Skin of Color Savvy: A New Podcast Episode Following SOCS Media Day

The HCPFive: Top News for Healthcare Providers from the Week of 11/16

The HCPFive: Top News for Healthcare Providers from the Week of 11/16

Latest News

Decisions about the HPV vaccine among adolescents and their families are influenced by a web of social, cultural and trust-related factors, beyond simple awareness or access, a Cochrane review finds.

A three-year campaign to bring vaccines against human papillomavirus (HPV) to low-income countries has prevented 1.4 million cervical cancer deaths, the vaccine alliance Gavi said Monday.

For more than three decades, researchers Christine Stabell Benn and Peter Aaby from the Bandim Health Project have conducted randomized trials involving thousands of children in Guinea-Bissau and Denmark to demonstrate so-called ...

Passengers traveling through Philadelphia International Airport over the weekend may have been exposed to a case of the measles, city health officials warned Tuesday.

Pertussis, also known as whooping cough, has reached a record high, with over 3,500 cases reported in Texas to date, according to a Texas Department of State Health Services health alert.

Researchers and scientists in South Africa on Tuesday launched clinical trials on the first domestically developed vaccine.

News All Time

California partnership aided COVID-19 response and health equity, report finds

The COVID-19 pandemic did not affect everyone equally. Communities of color, especially Latino (including undocumented persons), Black, and Native American groups, as well as people with low incomes, experienced much higher ...

CDC stops recommending COVID-19 shots for all, leaves decision to patients

The Centers for Disease Control and Prevention adopted recommendations by a new group of vaccine advisers, and stopped recommending COVID-19 shots for anyone—leaving the choice up to patients.

Study: Flu vaccine uptake consistently highest for Asian patients, lowest for Black patients

Persistent racial differences in flu vaccination uptake are seen across ages and flu seasons, according to a study published in the Oct. 3 issue of Vaccine.

A middle-ground framework for US vaccine policy

In a new JAMA Viewpoint, Lainie Friedman Ross, MD, Ph.D., chair of the Department of Health Humanities and Bioethics at the University of Rochester Medical Center, and Mark Navin, Ph.D., chair of Philosophy at Oakland University, ...

Opinion: Experts warn disaster looms following politicized US health changes

Authors from the American College of Physicians (ACP) warn that disaster looms ahead for the U.S. health care system, likely precipitated by an epidemic of vaccine-preventable and attenuating diseases. They say the politicization ...

RSV vaccine uptake in pregnancy linked to perinatal outcomes and health inequities

Uptake of the respiratory syncytial virus (RSV) vaccine during pregnancy is not linked to increased risk of adverse perinatal health outcomes among vaccinated women, according to research at City St George's and published ...

Chickenpox: Why the UK has approved the MMRV vaccine in under-fours but the US is preparing to restrict it

Two countries, two different approaches to protecting children from chickenpox. While the UK prepares to introduce a combined vaccine covering measles, mumps, rubella and chickenpox (MMRV) in a single jab, the US is moving ...

Despite escalating anti-vaccine rhetoric, most Americans support vaccine mandates, surveys find

At an explosive news conference on the causes of autism, President Donald Trump espoused decades-old, long-debunked theories linking autism to the childhood vaccine schedule.

Minnesota defies feds with COVID vaccine guidance

Minnesota's top doctor issued a standing order on Sept. 22 allowing pharmacists to give COVID-19 vaccines without prescriptions to a broader group of patients than federally recommended.

New vaccine panel recommends doctor consults before COVID shots

A new federal vaccine panel appointed by U.S. Health Secretary Robert F. Kennedy Jr. has recommended tighter restrictions on COVID-19 shots.

Vaccine mandates misinformation: Two experts explain the true role of slavery and racism

On Sept. 3, 2025, Florida announced its plans to be the first state to eliminate vaccine mandates for its citizens, including those for children to attend school.

Take the shot: Does the country's future hang on public health support?

The Advisory Committee on Immunization Practices recently linked 25 unverified reports of child deaths to COVID-19 vaccines as they consider further limiting access to this and other immunizations, like those for hepatitis ...

Illinois committee recommends state part ways with feds on COVID-19 vaccines

Illinois health leaders should part ways with the federal government when it comes to COVID-19 vaccines and recommend the shots for all adults and many children, an influential state committee voted Monday.

CDC advisers limit MMRV combo vaccine, delay hepatitis B vote

Top vaccine advisers hand-selected by Health Secretary Robert F. Kennedy Jr. voted Thursday to limit the use of a combination shot that protects against measles, mumps, rubella and chickenpox.

West Coast states issue their own COVID, flu, RSV vaccine rules

Four Western states are taking a different approach from the U.S. Centers for Disease Control and Prevention (CDC) on vaccines for COVID-19, flu and RSV.

US vaccine panel to hold high-stakes policy meeting

A US panel stacked with figures sympathetic to the anti-vaccine movement will on Thursday take on federal immunization recommendations in a highly politicized meeting that could upend longstanding medical advice.

Recommended News For You

Breast cancer-related fatigue: The benefits of adapted physical activity

Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT

Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma

Study opens up possibility of bespoke prostate cancer treatment

According to a study, there is now a 94 percent survival rate for children with acute lymphatic leukemia.

Analysis of projected cancer rates in Canada by 2024.

Researchers investigate risk of developing multiple primary cancers after surviving bowel cancer

Recommended Articles For You

Single-Cell Lineage Tracing in Hematology: Decoding the Cellular Blueprint of Blood Disorders 

Managing High Potassium Levels: A Comprehensive Guide to Veltassa  

Late Effects of Immunotherapy in Chronic Melanoma Survivorship with Repurposed Drugs 

Ticagrelor Monotherapy vs. Ticagrelor + Aspirin in ACS Post-PCI: ULTIMATE-DAPT Trial 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Launch of the hereditary cancer clinic for precision oncology at Kokilaben Hospital.

2.

Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?

3.

From sweetener to cancer fighter? Fermented stevia shows promise in pancreatic cancer study

4.

Large, Grade 4 Kidney Tumors Pose Risk of Early Cancer-Specific Mortality

5.

C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.

1.

Synovial Sarcoma of Female Urethra: Case Report and Literature Review

2.

Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis

3.

Unlocking the Potential of Plinabulin: A New Frontier in Cancer Treatment

4.

All You Need To Know About Partial Thromboplastin Time (PTT) Test

5.

From Autoimmune Disorders to COVID-19: How Plasmapheresis Is Revolutionizing Modern Medicine 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

2.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

3.

Navigating the Complexities of Ph Negative ALL - Part XII

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot